Search Results - "FITZSIMMONS, W. E"

Refine Results
  1. 1
  2. 2

    Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation by KERSHNER, R. P, FITZSIMMONS, W. E

    Published in Transplantation (15-10-1996)
    “…FK506 (tacrolimus) is a safe and effective immunosuppressant for the prevention of organ rejection after organ transplantation. FK506 has a relatively narrow…”
    Get full text
    Journal Article
  3. 3

    Association of Discharge Immunosuppression Regimen and Post-Transplant Outcomes in Lung Transplantation: An Analysis of OPTN Data by Cherikh, W.S., Plucinski, B.J., Palmer, S., Fitzsimmons, W.E.

    “…The optimal immunosuppressive (IS) regimen after lung (LU) transplant is unknown, therefore we sought to examine OPTN data to compare the impact of 4 different…”
    Get full text
    Journal Article
  4. 4

    Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant Patients by Venkataramanan, Raman, Shaw, Leslie M., Sarkozi, Laszlo, Mullins, Richard, Pirsch, John, MacFarlane, Gordon, Scheller, Dan, Ersfeld, Diana, Frick, Mary, Fitzsimmons, William E., Virji, Mohammed, Jain, Ashok, Brayman, Kenneth L., Shaked, Abraham

    Published in Journal of clinical pharmacology (01-05-2001)
    “…The relationship between the dose of tacrolimus, trough tacrolimus blood concentration, and selected clinical endpoints (acute rejection, nephrotoxicity, and…”
    Get full text
    Journal Article
  5. 5

    Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat by MINH DIEM VU, QI, S, XU, D, WU, J, FITZSIMMONS, W. E, SEHGAL, S. N, DUMONT, L, BUSQUE, S, DALOZE, P, CHEN, H

    Published in Transplantation (27-12-1997)
    “…Combined use of tacrolimus (FK506) with sirolimus (rapamycin [RAPA]) was examined in a model of vascularized heart allograft in the rat. For prevention of…”
    Get full text
    Conference Proceeding Journal Article
  6. 6

    Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey by SHIJIE QI, DASHENG XU, HUIFANG CHEN, JUNZHENG PENG, MINH DIEM VU, JIANGPING WU, BEKERSKY, I, FITZSIMMONS, W. E, PEETS, J, SEHGAL, S, DALOZE, P

    Published in Transplantation (15-04-2000)
    “…Our previous studies confirmed that tacrolimus (FK506) and sirolimus [rapamycin (RAPA)], in combination, are not antagonistic but are synergistic in the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    4-Aminopyridine in multiple sclerosis : prolonged administration by STEFOSKI, D, DAVIS, F. A, FITZSIMMONS, W. E, LUSKIN, S. S, RUSH, D. J, PARKHURST, G. W

    Published in Neurology (01-09-1991)
    “…In an earlier study, we demonstrated efficacy of single oral doses of 4-aminopyridine (4-AP) in improving motor and visual signs in multiple sclerosis (MS)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Compromised kidney graft rejection response in vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus by HUIFANG CHEN, JUNZHENG PENG, BEKERSKY, I, PEETS, J, SEHGAL, S. N, JIANGPING WU, HONGYU LUO, LOUBEAU, M, XIAOCHUN WAN, DASHENG XU, SHIJIE QI, MINH DIEM VU, DALOZE, P, FITZSIMMONS, W. E

    Published in Transplantation (27-04-2000)
    “…In nonprimates, organ allografts are often not rejected after withdrawal of immunosuppression. In this study, we examined whether such a phenomenon also occurs…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin by SWENSON, C. E, STEWART, K. A, HAMMETT, J. L, FITZSIMMONS, W. E, GINSBERG, R. S

    Published in Antimicrobial Agents and Chemotherapy (01-02-1990)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation by YU, C, SEIDEL, K, FITZSIMMONS, W. E, SALE, G, STORB, R

    Published in Bone marrow transplantation (Basingstoke) (01-07-1997)
    “…Several steroid receptor-associated heat shock proteins can bind to FK506 as immunophilins. This has led to speculation that the steroid receptor and…”
    Get full text
    Journal Article
  15. 15

    Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation by Ghalie, R, Fitzsimmons, W E, Weinstein, A, Manson, S, Kaizer, H

    Published in The Annals of pharmacotherapy (01-03-1994)
    “…The principal objective of this study was to determine whether a relationship exists between trough cyclosporine concentrations measured by HPLC and the…”
    Get more information
    Journal Article
  16. 16

    Cortical blindness: a rare complication of cyclosporine therapy by Ghalie, R, Fitzsimmons, W E, Bennett, D, Kaizer, H

    Published in Bone marrow transplantation (Basingstoke) (01-08-1990)
    “…We report a bone marrow transplant patient who developed a reversible episode of cortical blindness, a rare complication of cyclosporine therapy. We review…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation by Yu, C, Storb, R, Deeg, H J, Graham, T C, Scheuning, F G, Huss, R, Seidel, K, Fitzsimmons, W E

    Published in Bone marrow transplantation (Basingstoke) (01-04-1996)
    “…We previously reported an synergism between methotrexate and tacrolimus (FK506) in preventing graft-versus-host disease (GVHD) in dogs given DLA-nonidentical…”
    Get more information
    Journal Article
  20. 20